Latest News Feed

Study aims to identify novel blood-based inflammatory markers that can be used to both identify and stratify Parkinson's disease patients

Broadens immunomodulatory peptide portfolio while also expanding route of administration capabilities

Launches preclinical development effort of LBT-3627 as a neuroprotective/repair treatment for Multiple Sclerosis